Patient Perceptions in Mast Cell Disorders

Immunol Allergy Clin North Am. 2018 Aug;38(3):505-525. doi: 10.1016/j.iac.2018.04.006.

Abstract

Understanding experiences, perceptions, and perspectives of patients with a mast cell disorder (MCD), including cutaneous mastocytosis, systemic mastocytosis, mast cell activation syndromes, and hereditary α-tryptasemia, is an important aspect of successful care, treatment, and informed development of novel therapies. This article reviews existing studies and presents new data on MCD patient perceptions regarding medical care, symptoms, allergies/sensitivities, triggers, future health/disease progression, treatment, impact on daily living, quality of life, support needs, and concerns regarding possible familial disease. Discussion includes aspects affecting the MCD community that require further consideration and development.

Keywords: Anaphylaxis; Disability; Mast cell activation; Mast cell disorder; Patient perceptions and experiences; Quality of life; Support; The Mastocytosis Society.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Emotions
  • Government Regulation
  • Humans
  • Mast Cells / physiology*
  • Mastocytosis / epidemiology*
  • Mastocytosis / psychology
  • Patient Preference*
  • Patient Reported Outcome Measures*
  • Perception*
  • Physician-Patient Relations
  • Quality of Life
  • United States
  • United States Food and Drug Administration